----item----
version: 1
id: {8BAFA3A9-7294-4A63-817E-4621981EB027}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/Mergers amp Acquisitions 2010
parent: {D5B965D3-AC3D-4A7F-90E6-65193022C6B5}
name: Mergers amp Acquisitions 2010
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: bfc87017-bec2-42a8-82d3-fbbcbfaefb52

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 1161

<p> <tbody> <tr> </tr> <tr> <td> <tbody> <tr> <td>The latest medtech deals, as and when it happens<a></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2010 so far. </td> </tr> <tr> <td><strong><a>M&amp;A 2012</a></strong></td> <td><strong><a>M&amp;A 2011</a></strong></td> <td><strong>M&amp;A 2010</strong></td> <td><strong><a>FREE TRIAL</a></strong></td> </tr> </tbody> </td> </tr> <tr> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> </tr> <tr> <td><div><a>Deals</a></div></td> <td><div><a>M&amp;A </a></div></td> <td><div><a>Financials</a></div></td> <td><div><a>Funding </a></div></td> <td><div><a>Legal</a></div></td> <td><div><a>Start-ups &amp; SMEs </a></div></td> <td><div><a>Market Monitor </a></div></td> <td><div><a>Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody>  </p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 31

Mergers &amp; Acquisitions 2010
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 72703

<p><table> <tbody> <tr> </tr> <tr> <td colspan="8" scope="row" widtd="101"><table> <tbody> <tr> <td colspan="4" scope="row" widtd="101">The latest medtech deals, as and when it happens<a name="top" id="top"></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2010 so far. </td> </tr> <tr> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/MnA/" class="optionsLink">M&amp;A 2012</a></strong></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a class="optionsLink" href="http://www.clinica.co.uk/MnA/_2011/">M&amp;A 2011</a></strong></td> <td bgcolor="#CCCCCC" scope="row" widtd="101"><strong>M&amp;A 2010</strong></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/freetrial/" class="optionsLink">FREE TRIAL</a></strong></td> </tr> </tbody> </table></td> </tr> <tr> <td><a href="http://www.clinica.co.uk/business/"><img src="-/media/A41DB0E6789340E3BBE2BB586EBE4293.ashx" alt="Deals" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/"><img src="-/media/1594690D6C314ABFA668C2F281D90DEC.ashx" alt="M&amp;A" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/financials/"><img src="-/media/873669F6772642DC9C0C091A39B44486.ashx" alt="Financials" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><div><a href="http://www.clinica.co.uk/business/funding/"><img src="-/media/B1AB1227A20C433897DB3C8B2F140E45.ashx" alt="Funding" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/legal/"><img src="-/media/7D0516FC157A4E1F896F543962188904.ashx" alt="Legal" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/start-upssmes/"><img src="-/media/66EE0878ED2E4CEC9D21449351C40077.ashx" alt="Start-ups &amp; SMEs" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/marketmonitor/"><img src="-/media/808B4B2204F542438455FA3DB83F4C28.ashx" alt="Market Monitor" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/ma2/"><img src="-/media/7183F022AB364B8C8C43E7EC13518288.ashx" alt="Google Map" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> </tr> <tr> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/" class="optionsLink">Deals</a></div></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/" class="optionsLink">M&amp;A </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/financials/" class="optionsLink">Financials</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/funding/" class="optionsLink">Funding </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/legal/" class="optionsLink">Legal</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/start-upssmes/" class="optionsLink">Start-ups &amp; SMEs </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/marketmonitor/" class="optionsLink">Market Monitor </a></div></td> <td><div><a href="http://www.clinica.co.uk/ma2/" class="optionsLink">Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody> </table> </p> <p><p> <table> <tr> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Acquirer </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Target </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Industry sector </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Price paid </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Date announced </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Date completed </b> </p> </th> </tr> <tr> <td> <p> <b>MiMedx (US)</b> </p> </td> <td> <p> Surgical Biologics (US) </p> </td> <td> <p> Surgical implants </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/MiMedx-to-buy-Surgical-Biologics-for-biomaterial-boost-308021?autnID=/contentstore/clinica/codex/1050e291-1819-11e0-973d-774b2a893566.xml">December 2010</a> </p> </td> <td> <p> January 2011 </p> </td> </tr> <tr> <td> <p> <b>SyntheMed (US)</b> </p> </td> <td> <p> Pathfinder (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> Undisclosed merger </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cellulargenetic/SyntheMed-and-Pathfinder-merge-to-create-cell-based-tech-firm-307979?autnID=/contentstore/clinica/codex/54f81673-14d1-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> Sodem Diffusion (Switzerland) </p> </td> <td> <p> Surgical power tools </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Zimmer-buys-Sodem-Diffusion-for-power-tools-boost-307849?autnID=/contentstore/clinica/codex/0cef6da3-0e8d-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Pritzker Group (US)</b> </p> </td> <td> <p> Clinical Innovations (US) </p> </td> <td> <p> Women's health </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Gen-Probe (US)</b> </p> </td> <td> <p> GTI Diagnostics (US) </p> </td> <td> <p> Transplant diagnostics </p> </td> <td> <p> $53m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Gen-Probe-acquires-blood-diagnostics-specialist-GTI-307693?autnID=/contentstore/clinica/codex/2c93ffe4-0d01-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Chart Industries (US)</b> </p> </td> <td> <p> SeQual Technologies (US) </p> </td> <td> <p> Air separation technology </p> </td> <td> <p> $40m </p> </td> <td> <p> December 2010 </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Samsung (Korea)</b> </p> </td> <td> <p> Medison (Korea) </p> </td> <td> <p> Medical equipment </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>iCAD (US)</b> </p> </td> <td> <p> Xoft (US) </p> </td> <td> <p> Brachytherapy </p> </td> <td> <p> $13.1m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/iCAD-enters-cancer-treatment-sector-with-Xoft-buy-307647?autnID=/contentstore/clinica/codex/58bd8f7e-0c36-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Thermo Fisher (US)</b> </p> </td> <td> <p> Dionex (US) </p> </td> <td> <p> Chromatography </p> </td> <td> <p> $2.1bn </p> </td> <td> <p> December 2010 </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Galderma (US)</b> </p> </td> <td> <p> Q-Med (Sweden) </p> </td> <td> <p> Medical implants </p> </td> <td> <p> SEK75 ($11) per share </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/Nestle-and-LOreal-joint-venture-to-make-bid-for-Q-Med-307456?autnID=/contentstore/clinica/codex/a920ed01-085e-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>3i (UK)</b> </p> </td> <td> <p> OneMed Group from CapMan (Norway) </p> </td> <td> <p> Medical device wholesaler </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/OneMed-sold-to-3i-in-private-equity-deal-307363?autnID=/contentstore/clinica/codex/5b053692-076e-11e0-bd26-b56fabe1b06f.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Phadia (Sweden)</b> </p> </td> <td> <p> Wei Kang Le (China) </p> </td> <td> <p> Device distributor </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Phadia-set-to-buy-Chinese-allergy-test-distributor-307303?autnID=/contentstore/clinica/codex/99bc02c5-06ce-11e0-bd26-b56fabe1b06f.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Synergy Health (UK)</b> </p> </td> <td> <p> Gamma-Service-Produktbestrahlung (Germany) </p> </td> <td> <p> Device sterilisation </p> </td> <td> <p> &euro;9.5m ($12.6m) </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/Synergy-Health-grows-European-sterilisation-business-307312?autnID=/contentstore/clinica/codex/53c946f6-06b2-11e0-bd26-b56fabe1b06f.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Olympus (Japan)</b> </p> </td> <td> <p> Stryker's OP-1 family of biological bone substitutes (US) </p> </td> <td> <p> Orthopaedic </p> </td> <td> <p> $60m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Stryker-offloads-troubled-orthobiologics-line-to-Olympus-for-60m-307020?autnID=/contentstore/clinica/codex/bb9bfbef-0217-11e0-a987-953107add0d4.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Axis-Shield (UK)</b> </p> </td> <td> <p> Clinical chemistry homocysteine business from Catch (US) </p> </td> <td> <p> IVD </p> </td> <td> <p> $10m and 10% products revenue for the life of the technology </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Axis-Shield-to-acquire-homocysteine-testing-products-from-Catch-307019?autnID=/contentstore/clinica/codex/fc2823f7-0216-11e0-a987-953107add0d4.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Transgenomic (US)</b> </p> </td> <td> <p> Genetic and companion diagnostic testing business of Clinical Data (US) </p> </td> <td> <p> IVD </p> </td> <td> <p> $15.4m cash and stock, plus milestones </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Transgenomic-to-acquire-molecular-Dx-tech-from-Clinical-Data-306940?autnID=/contentstore/clinica/codex/f1e71bb6-0149-11e0-a987-953107add0d4.xml">December 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Thermo Fisher Scientific (US)</b> </p> </td> <td> <p> Lomb Scientific (Australia) </p> </td> <td> <p> Laboratory consumables and instruments </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Thermos-Lomb-buy-to-expand-Asia-Pacific-presence-306882?autnID=/contentstore/clinica/codex/da954ab6-feef-11df-a987-953107add0d4.xml">December 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>EKF Diagnostics (Germany)</b> </p> </td> <td> <p> Argutus Medical (Ireland) </p> </td> <td> <p> IVD </p> </td> <td> <p> &pound;2.2m ($3.3m) </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Refocused-EKF-snaps-up-Argutus-as-third-IVD-buy-306873?autnID=/contentstore/clinica/codex/a21e9fbc-fed1-11df-a987-953107add0d4.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Ardian (US) </p> </td> <td> <p> Catheter-based treatment for hypertension </p> </td> <td> <p> $800m and milestones </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Medtronic-to-buy-hypertension-catheter-firm-in-800m-transaction-306404?autnID=/contentstore/clinica/codex/971dbbc3-f6f6-11df-94df-b10cef61aec8.xml">November 2010</a> </p> </td> <td> <p> January 2011 </p> </td> </tr> <tr> <td> <p> <b>LeMaitre Vascular (US)</b> </p> </td> <td> <p> Lifespan vascular graft manufacturing business from Angiotech Pharmaceuticals (US) </p> </td> <td> <p> Vascular grafts </p> </td> <td> <p> $2.8m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/LeMaitre-buys-Lifespan-vascular-graft-technology-306362?autnID=/contentstore/clinica/codex/15ab6edd-f64f-11df-9311-6b6095da2766.xml">November 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> Sadra Medical (US) </p> </td> <td> <p> Transcatheter aortic valve implantation </p> </td> <td> <p> $225m and milestones of up to $225m through 2016 </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Boston-follows-Medtronics-footsteps-and-buys-into-TAVI-space-306356?autnID=/contentstore/clinica/codex/2a9afa13-f645-11df-9311-6b6095da2766.xml">November 2010</a> </p> </td> <td> <p> January 2011 </p> </td> </tr> <tr> <td> <p> <b>BTG (UK)</b> </p> </td> <td> <p> Biocompatibles (US) </p> </td> <td> <p> Bead technology </p> </td> <td> <p> &pound;177.2m ($284.4m) </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/BTG-snaps-up-Biocompatibles-306267?autnID=/contentstore/clinica/codex/90239a64-f3d5-11df-9311-6b6095da2766.xml">November 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Wilex (Germany)</b> </p> </td> <td> <p> Oncogene Science assets from Siemens (US) </p> </td> <td> <p> Gene-based cancer ELISA assays </p> </td> <td> <p> &euro;500,000 ($682,220) </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Wilex-acquires-cancer-diagnostics-assets-from-Siemens-gains-US-access-306146?autnID=/contentstore/clinica/codex/20c45b5b-f31b-11df-9311-6b6095da2766.xml">November 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Omega Diagnostics (UK)</b> </p> </td> <td> <p> Allergopharma Joachim Ganzer (Germany) </p> </td> <td> <p> Allergy testing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Omega-buys-Allergopharmas-allergy-IVD-assets-outlines-sales-growth-strategy-306052?autnID=/contentstore/clinica/codex/0edec1c1-f24c-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Ecolab (US)</b> </p> </td> <td> <p> OR Solutions (US) </p> </td> <td> <p> Surgical fluid warming and cooling </p> </td> <td> <p> $260m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Ecolab-grows-healthcare-business-with-OR-Solutions-buy-305993?autnID=/contentstore/clinica/codex/d8fb0ad1-f176-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Optos (UK) </b> </p> </td> <td> <p> Opto Global (Australia) </p> </td> <td> <p> Optometry and ophthalmology </p> </td> <td> <p> $10.75m cash, $1m in shares and milestones of $3m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Optos-grows-globally-with-first-acquisition-305886?autnID=/contentstore/clinica/codex/bb921db3-ee6f-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>CardioNet (US)</b> </p> </td> <td> <p> Biotel (US) </p> </td> <td> <p> Wireless medtech </p> </td> <td> <p> $11m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/CardioNet-makes-peace-with-Biotel-and-signs-acquisition-agreement-305691?autnID=/contentstore/clinica/codex/ec6ad042-ec0c-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Synthes (US)</b> </p> </td> <td> <p> The Anspach Effort (US) </p> </td> <td> <p> Surgical </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Synthes-buys-Anspach-to-create-200m-power-tools-division-305597?autnID=/contentstore/clinica/codex/fe8c9b94-eb46-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Warburg Pincus (US)</b> </p> </td> <td> <p> International Technidyne Corporation from Thoratec (US) </p> </td> <td> <p> Point-of-care testing </p> </td> <td> <p> $55m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Thoratecs-ITC-sold-to-Warburg-Pincus-merges-with-Nexus-305555?autnID=/contentstore/clinica/codex/a7b5d4ba-e8f4-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Nordson (US)</b> </p> </td> <td> <p> Micromedics (US) </p> </td> <td> <p> Biomaterials </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Nordson-grows-biomaterials-portfolio-with-Micromedics-buy-305471?autnID=/contentstore/clinica/codex/dbfc511a-e809-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Cascade Technologies (US) </b> </p> </td> <td> <p> AcuNetx (US) </p> </td> <td> <p> Balance disorders </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Cascade-eyes-AcuNetx-purchase-for-optical-tech-growth-305470?autnID=/contentstore/clinica/codex/814267b3-e804-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Orbotech Medical Solutions (US) </p> </td> <td> <p> Nuclear Imaging </p> </td> <td> <p> $14m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/GE-builds-nuclear-imaging-business-with-Orbotech-purchase-305321?autnID=/contentstore/clinica/codex/0c6ecf72-e68d-11df-b56b-d9efd72640a9.xml">November 2010</a> </p> </td> <td> <p> February 2011 </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Porex Surgical (US) </p> </td> <td> <p> Biomaterials </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Stryker-lands-Porex-Surgical-for-CMF-growth-305262?autnID=/contentstore/clinica/codex/33d151e9-e5c8-11df-8ff6-0fe54ab79eac.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Wright Medical (US)</b> </p> </td> <td> <p> EZ Frame from EZ Concept Surgical Device (US) </p> </td> <td> <p> Foot fixation </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Wright-Medical-suffers-shares-dip-after-guidance-cut-305256?autnID=/contentstore/clinica/codex/83556b11-e5c7-11df-8ff6-0fe54ab79eac.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Coloplast (Denmark)</b> </p> </td> <td> <p> Mpathy Medical (UK) </p> </td> <td> <p> Female pelvic health </p> </td> <td> <p> $30m with $5m in earn-out fees </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Coloplast-buys-UK-womens-health-firm-for-30m-305189?autnID=/contentstore/clinica/codex/4cb0fb44-e350-11df-8ff6-0fe54ab79eac.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Neurovascular product line from Boston Scientific (US) </p> </td> <td> <p> Neurovascular </p> </td> <td> <p> $1.5bn </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/neurological/Stryker-set-for-expansion-with-Boston-neurovascular-buy-305132?autnID=/contentstore/clinica/codex/431f3ec8-e2a0-11df-8ff6-0fe54ab79eac.xml">October 2010</a> </p> </td> <td> <p> January 2011 </p> </td> </tr> <tr> <td> <p> <b>Endologix (US)</b> </p> </td> <td> <p> Nellix (US) </p> </td> <td> <p> Endografts </p> </td> <td> <p> $15m in stock and $39m in milestones </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Endologix-to-buy-Nellix-for-endograft-boost-305098?autnID=/contentstore/clinica/codex/5c305427-e27b-11df-8ff6-0fe54ab79eac.xml">October 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Diagn�sticos da América (Brazil)</b> </p> </td> <td> <p> CERPE Diagn�sticos (Brazil) </p> </td> <td> <p> Lab diagnostics </p> </td> <td> <p> R$51.5m (US$30.3m) </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Brazils-DASA-expands-with-CERPE-acquisition-305093?autnID=/contentstore/clinica/codex/f61e1fab-e204-11df-8ff6-0fe54ab79eac.xml">October 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Nexcore (US)</b> </p> </td> <td> <p> Meditron line from CooperSurgical (US) </p> </td> <td> <p> Gastroeneterology endoscopy </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/CooperSurgical-divests-gastroenterology-products-to-Nexcore-305051?autnID=/contentstore/clinica/codex/b79fc678-e1d1-11df-8ff6-0fe54ab79eac.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Clarient (US) </p> </td> <td> <p> Diagnostics </p> </td> <td> <p> $850m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/GEs-Clarient-buy-marks-significant-IVD-move-304995?autnID=/contentstore/clinica/codex/d7b5c5a7-e10e-11df-92b6-f9c7a3dcf22b.xml">October 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Vascular Solutions (US) </b> </p> </td> <td> <p> Snare technology form Radius Medical (US)<b> </b> </p> </td> <td> <p> Cardiovascular<b> </b> </p> </td> <td> <p> $5m in cash and $1.5m in cash milestones<b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Vascular-Solutions-buys-snare-tech-from-Radius-304965?autnID=/contentstore/clinica/codex/be389d83-e0e8-11df-92b6-f9c7a3dcf22b.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Biosign Technologies (Canada)</b> </p> </td> <td> <p> Healthanywhere (Canada) </p> </td> <td> <p> Patient monitoring </p> </td> <td> <p> $4.3m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/Biosign-buys-Healthanywhere-in-e-health-fit-304917?autnID=/contentstore/clinica/codex/21ecbcf9-e02c-11df-92b6-f9c7a3dcf22b.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Biosensors International Group (Singapore)</b> </p> </td> <td> <p> Devax (US) </p> </td> <td> <p> Birfurcation stents </p> </td> <td> <p> $5.7m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Biosensors-strengthens-stent-portfolio-with-Devax-buy-304855?autnID=/contentstore/clinica/codex/6ffd2d16-dde0-11df-92b6-f9c7a3dcf22b.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Exagen (US)</b> </p> </td> <td> <p> Diagnostic business from Cypress Bioscience (US) </p> </td> <td> <p> Genomic testing </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> October 2010 </p> </td> </tr> <tr> <td> <p> <b>Woodbury Health Products (US)</b> </p> </td> <td> <p> Wilmington Medical Supply (US) </p> </td> <td> <p> Home medical supplies distribution </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> October 2010 </p> </td> </tr> <tr> <td> <p> <b>Opto Circuits (India)</b> </p> </td> <td> <p> Cardiac Science (US) </p> </td> <td> <p> Cardiology </p> </td> <td> <p> $2.30 in cash per share </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Indias-Opto-Circuits-ups-US-cardio-stake-with-Cardiac-Science-buy-304561?autnID=/contentstore/clinica/codex/cd2d5fed-dc3e-11df-92b6-f9c7a3dcf22b.xml">October 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>St Jude Medical (US)</b> </p> </td> <td> <p> AGA Medical (US) </p> </td> <td> <p> Cardiovascular </p> </td> <td> <p> $1.03bn </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/St-Jude-breaks-new-ground-with-1.03bn-AGA-purchase-304478?autnID=/contentstore/clinica/codex/c02e457a-dac3-11df-92b6-f9c7a3dcf22b.xml">October 2010</a> </p> </td> <td> <p> November 2010 </p> </td> </tr> <tr> <td> <p> <b>Natus Medical (US)</b> </p> </td> <td> <p> Medix (Argentina) </p> </td> <td> <p> Newborn care </p> </td> <td> <p> $14m + potential additional fee related to revenue </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Natus-expands-Latin-American-stake-with-Medix-purchase-304289?autnID=/contentstore/clinica/codex/025243d4-d777-11df-8e2e-814ecd1e9957.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Stanmore Implants Worldwide (UK)</b> </p> </td> <td> <p> Acrobot (UK) </p> </td> <td> <p> Robotic surgery </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Stanmore-to-offer-ortho-implant-placement-tech-with-Acrobot-buy-304181?autnID=/contentstore/clinica/codex/bc164bb1-d5ec-11df-8e2e-814ecd1e9957.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Argon Medical (US)</b> </p> </td> <td> <p> Critical care and extended dwell catheter divisions from BD (US) </p> </td> <td> <p> Critical care </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Argon-Medical-to-purchase-BD-critical-care-division-303844?autnID=/contentstore/clinica/codex/9e6fa45e-d136-11df-8e2e-814ecd1e9957.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>The Riverside Company (US)</b> </p> </td> <td> <p> Life sciences and industrial division of EXFO (Canada) </p> </td> <td> <p> Cellular imaging </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/EXFOs-life-sciences-division-goes-to-private-buyer-303781?autnID=/contentstore/clinica/codex/205a493b-d06b-11df-8e2e-814ecd1e9957.xml">October 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Crocker Ventures (US)</b> </p> </td> <td> <p> TMJ Implants (US) </p> </td> <td> <p> Jaw implants </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Crocker-saves-TMJ-Implants-with-takeover-deal-303588?autnID=/contentstore/clinica/codex/6de83ed6-cc93-11df-8e2e-814ecd1e9957.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Virtual Radiologic (US)</b> </p> </td> <td> <p> NightHawk Radiology (US) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> $170m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/vRad-bumps-up-radiology-coverage-with-NightHawk-buy-303499?autnID=/contentstore/clinica/codex/385dbc63-cbaa-11df-a32e-d7a62abdf853.xml">September 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Fujirebio (Japan)</b> </p> </td> <td> <p> Abbott's Innogenetics subsidiary (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> &yen;9.8bn ($112.9m) </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Abbott-offloads-Innogenetics-to-Fujirebio-303290?autnID=/contentstore/clinica/codex/df889d36-c7e3-11df-a32e-d7a62abdf853.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Texas Oncology (US)</b> </p> </td> <td> <p> Hyperthermia treatment technology from BSD Medical (US) </p> </td> <td> <p> Cancer treatment </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Texas-Oncology-buys-BSDs-hyperthermia-treatment-system-303215?autnID=/contentstore/clinica/codex/91bf4c06-c6fe-11df-a32e-d7a62abdf853.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Amedica (US)</b> </p> </td> <td> <p> US Spine (US) </p> </td> <td> <p> Spinal </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Amedica-buys-US-Spine-for-sales-boost-303183?autnID=/contentstore/clinica/codex/713adcb0-c63a-11df-a32e-d7a62abdf853.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> Asthmatx (US) </p> </td> <td> <p> Bronchial thermoplasty </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Boston-portfolio-reconstruction-begins-with-Asthmatx-purchase-303042?autnID=/contentstore/clinica/codex/ed037cfd-c4ce-11df-a32e-d7a62abdf853.xml">September 2010</a> </p> </td> <td> <p> October 2010 </p> </td> </tr> <tr> <td> <p> <b>Cord Blood America (US)</b> </p> </td> <td> <p> Majority stake in Biocordcell Argentina (Argentina) </p> </td> <td> <p> Stem cell storage </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cellulargenetic/Cord-Blood-America-gains-majority-stake-in-South-American-stem-cell-firm-303037?autnID=/contentstore/clinica/codex/79006853-c4a2-11df-a32e-d7a62abdf853.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>3M (US)</b> </p> </td> <td> <p> Arizant (US) </p> </td> <td> <p> Temperature management </p> </td> <td> <p> $810m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/3M-paying-over-the-odds-for-recent-medtech-acquistionsacquisitions-302883?autnID=/contentstore/clinica/codex/05301da0-c0bf-11df-a828-bb48b6b57bf5.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Carestream Health (US)</b> </p> </td> <td> <p> Quantum Medical Imaging (US) </p> </td> <td> <p> X-ray </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Carestream-grows-X-ray-offering-with-Quantum-acquisition-302415?autnID=/contentstore/clinica/codex/338364ae-bb2f-11df-a97f-333fc5882530.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>St Jude Medical (US)</b> </p> </td> <td> <p> 19% stake in CardioMEMS (US) </p> </td> <td> <p> Wireless monitoring </p> </td> <td> <p> $60m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/St-Jude-gains-stake-in-CardioMEMS-with-view-to-buy-302360?autnID=/contentstore/clinica/codex/97849f5f-ba82-11df-a97f-333fc5882530.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Erba Diagnostics Mannheim (Germany)</b> </p> </td> <td> <p> Majority stake in IVAX Diagnostics (US) </p> </td> <td> <p> IVD </p> </td> <td> <p> $15m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Erba-becomes-major-shareholder-in-Ivax-Diagnostics-302265?autnID=/contentstore/clinica/codex/13d2b52b-b765-11df-a97f-333fc5882530.xml">September 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Power3 Medical Products (US)</b> </p> </td> <td> <p> Rozetta-Cell Life Sciences (US) </p> </td> <td> <p> Stem cell imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> September 2010 </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>NextImage Medical (US)</b> </p> </td> <td> <p> SelectMRI (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> September 2010 </p> </td> </tr> <tr> <td> <p> <b>Veritas Capital Fund (US)</b> </p> </td> <td> <p> Lighting and sensor business from PerkinElmer (US) </p> </td> <td> <p> Lighting and sensors </p> </td> <td> <p> $500m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/PerkinElmer-to-sell-lighting-and-sensor-business-to-private-equity-302144?autnID=/contentstore/clinica/codex/fb1bf92c-b5d5-11df-a97f-333fc5882530.xml">August 2010</a> </p> </td> <td> <p> November 2010 </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Gaymar Industries (US) </p> </td> <td> <p> Patient handling equipment </p> </td> <td> <p> $150m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Stryker-to-buy-Gaymar-Industries-for-billion-dollar-opportunity-301936?autnID=/contentstore/clinica/codex/07599fbc-b0fe-11df-a97f-333fc5882530.xml">August 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Roche (Switzerland)</b> </p> </td> <td> <p> BioImagene (US) </p> </td> <td> <p> Digital pathology </p> </td> <td> <p> $100m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Roche-to-buy-BioImagene-for-digital-pathology-boost-301893?autnID=/contentstore/clinica/codex/eca642db-b052-11df-a97f-333fc5882530.xml">August 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Sensus Healthcare (US)</b> </p> </td> <td> <p> Topex (US) </p> </td> <td> <p> Radiotherapy </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/imagingit/Sensus-builds-radiotherapy-business-with-Topex-buy-301587?autnID=/contentstore/clinica/codex/a02c52cf-ac4e-11df-8862-27eb9485523c.xml">August 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Anania &amp; Associates Investment (US)</b> </p> </td> <td> <p> Controlling interest in Lighthouse Imaging (US) </p> </td> <td> <p> Optical devices </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> August 2010 </p> </td> </tr> <tr> <td> <p> <b>Welsh, Carson, Anderson &amp; Stowe (US)</b> </p> </td> <td> <p> Majority stake in K2M (US) </p> </td> <td> <p> Spinal </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/K2M-receives-private-backing-for-portfolio-boost-301567?autnID=/contentstore/clinica/codex/9a2a1e70-ac40-11df-8862-27eb9485523c.xml">August 2010</a> </p> </td> </tr> <tr> <td> <p> <b>3M (US)</b> </p> </td> <td> <p> Attenti (Israel) </p> </td> <td> <p> Remote monitoring </p> </td> <td> <p> $230m </p> </td> <td><p></td> <td> <p> August 2010 </p> </td> </tr> <tr> <td> <p> <b>Exactech (US)</b> </p> </td> <td> <p> Minimally-invasive spine reconstruction portfolio from VertiFlex (US) </p> </td> <td> <p> Joint restoration </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> August 2010 </p> </td> </tr> <tr> <td> <p> <b>Medco Health Solutions (US)</b> </p> </td> <td> <p> United BioSource Corporation (US) </p> </td> <td> <p> Medtech and pharma data analytics </p> </td> <td> <p> $730m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Medco-to-buy-data-analytics-firm-for-730m-301377?autnID=/contentstore/clinica/codex/2115d52c-aaac-11df-8862-27eb9485523c.xml">August 2010</a> </p> </td> <td> <p> September 2010 </p> </td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Osteotech (US) </p> </td> <td> <p> Biologics </p> </td> <td> <p> $123m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Medtronic-to-broaden-regenerative-horizons-with-Osteotech-purchase-301323?autnID=/contentstore/clinica/codex/ee99f969-aa09-11df-8862-27eb9485523c.xml">August 2010</a> </p> </td> <td> <p> November 2010 </p> </td> </tr> <tr> <td> <p> <b>Topcon (Japan)</b> </p> </td> <td> <p> Glaucoma and retina assets of Optimedica (US) </p> </td> <td> <p> Therapeutic lasers </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Topcon-enters-therapeutic-laser-market-with-OptiMedica-unit-buy-301143?autnID=/contentstore/clinica/codex/274e5139-a607-11df-8862-27eb9485523c.xml">August 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Cyprotex (UK)</b> </p> </td> <td> <p> Apredica (US) </p> </td> <td> <p> Toxicology </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Cyprotex-doubles-US-share-with-Apredica-purchase-300790?autnID=/contentstore/clinica/codex/f429bd4a-a161-11df-88aa-f997b8fbcd19.xml">August 2010</a> </p> </td> </tr> <tr> <td> <p> <b>PerkinElmer (US)</b> </p> </td> <td> <p> VisEn Medical (US) </p> </td> <td> <p> Molecular Imaging </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/imagingit/PerkinElmer-buys-VisEn-to-expand-imaging-unit-300695?autnID=/contentstore/clinica/codex/d2d4d86b-a0a0-11df-88aa-f997b8fbcd19.xml">August 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Water Street Healthcare Partners (US)</b> </p> </td> <td> <p> Medical Specialities Distributors (US) </p> </td> <td> <p> Home infusion products </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/MSD-goes-to-Water-Street-for-private-ownership-300567?autnID=/contentstore/clinica/codex/6891a513-9eec-11df-9619-bdf33f7b45ad.xml">August 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Philips (the Netherlands)</b> </p> </td> <td> <p> CDP Medical (Israel) </p> </td> <td> <p> PACS </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Philips-grows-clinical-informatics-portfolio-with-Israeli-buy-300527?autnID=/contentstore/clinica/codex/b61757c7-9e41-11df-9619-bdf33f7b45ad.xml">August 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Opto Circuits (India)</b> </p> </td> <td> <p> Unetixs Vascular (US) </p> </td> <td> <p> Peripheral artery disease detection </p> </td> <td> <p> $9.7m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Indian-medtech-firm-buys-US-peripheral-arterial-disease-company-300521?autnID=/contentstore/clinica/codex/ca0be05c-9e37-11df-9619-bdf33f7b45ad.xml">July 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Clayton, Dubilier &amp; Rice and GS Capital Partners (US)</b> </p> </td> <td> <p> HGI Holdings from The Jordan Company (US) </p> </td> <td> <p> Medical device supply </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/HGI-changes-private-ownership-300397?autnID=/contentstore/clinica/codex/764ccb44-9bbe-11df-9cb7-d92b014200e2.xml">July 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Fresenius Medical Care (Germany)</b> </p> </td> <td> <p> Nikkiso Medical Korea (Republic of Korea) </p> </td> <td> <p> Diabetes care </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/Fresenius-ups-Asia-Pacific-coverage-with-Nikkiso-link-up-300157?autnID=/contentstore/clinica/codex/83939ddb-995a-11df-9cb7-d92b014200e2.xml">July 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> Beijing Montagne Medical Device (China) </p> </td> <td> <p> Orthopaedic implants </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Durom-recall-stills-weighs-down-Zimmer-second-quarter-300118?autnID=/contentstore/clinica/codex/a2b35233-98a9-11df-9cb7-d92b014200e2.xml">July 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Great Hill Partners and Primus Capital Funds (US)</b> </p> </td> <td> <p> SterilMed (US) </p> </td> <td> <p> Medical device reprocessing </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/SterilMed-goes-private-299762?autnID=/contentstore/clinica/codex/afefac75-9324-11df-870a-bbcce1c03e31.xml">July 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Biomet (US)</b> </p> </td> <td> <p> Cytosol Laboratories (US) </p> </td> <td> <p> Anticoagulants </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Biomet-acquires-anticoagulant-specialist-299758?autnID=/contentstore/clinica/codex/74faeb3f-931d-11df-870a-bbcce1c03e31.xml">July 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Masimo (US)</b> </p> </td> <td> <p> SEDLine (US) </p> </td> <td> <p> Brain monitoring </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Masimo-enters-brain-monitoring-market-with-SEDLine-purchase-299590?autnID=/contentstore/clinica/codex/e45be785-8f2e-11df-870a-bbcce1c03e31.xml">July 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Johnson &amp; Johnson (US)</b> </p> </td> <td> <p> Micrus Endovascular (US) </p> </td> <td> <p> Neurology </p> </td> <td> <p> $480m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/neurological/JandJ-to-add-Micrus-Endovascular-to-neuro-business-299517?autnID=/contentstore/clinica/codex/9ce4a150-8e6e-11df-870a-bbcce1c03e31.xml">July 2010</a> </p> </td> <td> <p> September 2010 </p> </td> </tr> <tr> <td> <p> <b>Philips (the Netherlands)</b> </p> </td> <td> <p> Shanghai Apex Electronics Technology (China) </p> </td> <td> <p> Ultrasound </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> July 2010 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Alcon (Switzerland)</b> </p> </td> <td> <p> LenSx Lasers (US) </p> </td> <td> <p> Eyecare </p> </td> <td> <p> $744m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Alcon-grows-cataract-surgical-offering-with-LenSx-buy-299335?autnID=/contentstore/clinica/codex/4f6a2bec-8b40-11df-870a-bbcce1c03e31.xml">July 2010</a> </p> </td> <td> <p> August 2010 </p> </td> </tr> <tr> <td> <p> <b>Hologic (US)</b> </p> </td> <td> <p> Sentinelle (Canada) </p> </td> <td> <p> Women's health </p> </td> <td> <p> $85m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Hologic-adds-MRI-to-breast-portfolio-with-Sentinelle-buy-299207?autnID=/contentstore/clinica/codex/e2fff2c0-89b3-11df-870a-bbcce1c03e31.xml">July 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Biocompatibles International (UK)</b> </p> </td> <td> <p> Patents protecting bead technology from BioCure (US) </p> </td> <td> <p> Oncology </p> </td> <td> <p> $4.5m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Biocompatibles-gets-share-price-boost-after-bead-patent-buy-299153?autnID=/contentstore/clinica/codex/dfffecd7-8904-11df-870a-bbcce1c03e31.xml">July 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Arrhythmia Research Technology (US)</b> </p> </td> <td> <p> RMDDx (Canada) </p> </td> <td> <p> Mobile Health </p> </td> <td> <p> $0.84m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Arrhythmia-Research-Technology-buys-mobile-health-tech-specialist-298723?autnID=/contentstore/clinica/codex/c9c8e0a0-8441-11df-870a-bbcce1c03e31.xml">June 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Xcounter (Sweden)</b> </p> </td> <td> <p> Ajat (Finland) </p> </td> <td> <p> Solid-state detection </p> </td> <td> <p> &pound;1.1m ($1.7m) for remaining 50.2% stake </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/imagingit/XCounter-buys-up-rest-of-Finnish-digital-imaging-firm-298558?autnID=/contentstore/clinica/codex/ac2c26e8-836e-11df-870a-bbcce1c03e31.xml">June 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Olympus (Japan)</b> </p> </td> <td> <p> Spiration (US) </p> </td> <td> <p> Respiratory </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Olympus-inhales-Spiration-to-grow-respiratory-unit-298428?autnID=/contentstore/clinica/codex/41467f04-8067-11df-870a-bbcce1c03e31.xml">June 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Piramal Healthcare (India)</b> </p> </td> <td> <p> BioSyntech (Canada) </p> </td> <td> <p> Hydrogels </p> </td> <td> <p> Can$3.9m (US$3.8m) </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/Piramal-acquires-assets-of-Canadian-medtech-firm-297982?autnID=/contentstore/clinica/codex/c0122957-7eaa-11df-870a-bbcce1c03e31.xml">June 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Covidien (Ireland)</b> </p> </td> <td> <p> Somanetics (US) </p> </td> <td> <p> Oximetry </p> </td> <td> <p> $250m net of cash acquired </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Covidien-to-add-Somanetics-in-250m-acquisition-297538?autnID=/contentstore/clinica/codex/8a45b4a6-7951-11df-870a-bbcce1c03e31.xml">June 2010</a> </p> </td> <td> <p> July 2010 </p> </td> </tr> <tr> <td> <p> <b>RoundTable Healthcare Partners (US)</b> </p> </td> <td> <p> Ophthalmic systems unit and certain parts of medical surgical systems business from BD (US) </p> </td> <td> <p> Opthalmic/ surgical </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/BD-set-to-divest-medtech-businesses-to-private-equity-firm-297079?autnID=/contentstore/clinica/codex/bedb8cac-73d2-11df-8763-db8ef8bae109.xml">June 2010</a> </p> </td> <td> <p> August 2010 </p> </td> </tr> <tr> <td> <p> <b>Sorin (Italy)</b> </p> </td> <td> <p> Gish Medical (US) </p> </td> <td> <p> Cardiovascular surgery </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Sorin-acquires-Gish-Biomedical-for-ECC-focus-297061?autnID=/contentstore/clinica/codex/e0609b67-73b0-11df-8763-db8ef8bae109.xml">June 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Tissue Regenix (UK)</b> </p> </td> <td> <p> Oxeco (UK) </p> </td> <td> <p> Vascular </p> </td> <td> <p> &pound;12m ($17.3m) </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Tissue-Regenix-eyes-AIM-listing-through-reverse-merger-with-Oxeco-297004?autnID=/contentstore/clinica/codex/99355b4e-72fc-11df-8763-db8ef8bae109.xml">June 2010</a> </p> </td> <td> <p> June 2010 </p> </td> </tr> <tr> <td> <p> <b>Huiheng Medical(China) </b> </p> </td> <td> <p> Portola Medical (US) </p> </td> <td> <p> Brachytherapy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Chinese-radiotherapy-firm-to-buy-former-NAS-breast-brachytherapy-technology-296861?autnID=/contentstore/clinica/codex/fad41230-6fda-11df-8763-db8ef8bae109.xml">June 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Covidien (Ireland) </p> </th> <td bordercolor="#FFFFFF"> <p> ev3 (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Vascular </p> </td> <td bordercolor="#FFFFFF"> <p> $2.8bn </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Covidien-rearranges-portfolio-with-ev3-purchase-296631?autnID=/contentstore/clinica/codex/9d18fd2f-6e4a-11df-8763-db8ef8bae109.xml">June 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> July 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> USHIFU (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Misonix (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Ultrasound </p> </td> <td bordercolor="#FFFFFF"> <p> $5.8m </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/USHIFU-grows-portfolio-with-SB500-and-Sonatherm-tech-296549?autnID=/contentstore/clinica/codex/a5211e27-6d70-11df-8763-db8ef8bae109.xml">May 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> SonoSite (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Visualsonics (Canada) </p> </td> <td bordercolor="#FFFFFF"> <p> Ultrasound </p> </td> <td bordercolor="#FFFFFF"> <p> $71m cash and debt </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/imagingit/SonoSite-to-strengthen-ultrasound-offering-with-Visualsonics-deal-296512?autnID=/contentstore/clinica/codex/c3d84bf2-6a59-11df-8763-db8ef8bae109.xml">May 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> June 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> St Jude Medical (US) </p> </th> <td bordercolor="#FFFFFF"> <p> LightLab Imaging (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Imaging </p> </td> <td bordercolor="#FFFFFF"> <p> $90m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/imagingit/St-Jude-set-to-buy-LightLab-in-90m-cash-deal-289450?autnID=/contentstore/clinica/codex/99de038c-641c-11df-bc1e-c5d67941f290.xml">May 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> July 2010 </p> </td> </tr> <tr> <td> <p> <b>Agilent Technologies (US)</b> </p> </td> <td> <p> Varian (US) </p> </td> <td> <p> Scientific Instrumentation and medical devices </p> </td> <td> <p> $1.5bn </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Biggest-medical-device-deal-this-year-as-Agilent-bags-Varian-173165?autnID=/contentstore/clinica/codex/aef57679-828f-11de-88a6-0ff13a4b0a77.xml">August 2009</a> </p> </td> <td> <p> May 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Aerocrine (Sweden) </p> </th> <td bordercolor="#FFFFFF"> <p> Apieron (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Airway management </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Aerocrine-buys-bankrupt-airway-tech-rival-289465?autnID=/contentstore/clinica/codex/cb329c4d-6410-11df-bc1e-c5d67941f290.xml">May 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Providence Equity Partners (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Virtual Radiologic (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Radiology software </p> </td> <td bordercolor="#FFFFFF"> <p> $294m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Virtual-Radiologic-to-go-private-with-294m-Providence-deal-289421?autnID=/contentstore/clinica/codex/8c96510b-63f6-11df-bc1e-c5d67941f290.xml">May 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> July 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Merit Medical Systems (US) </p> </th> <td bordercolor="#FFFFFF"> <p> BioSphere Medical (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Embolotherapy </p> </td> <td bordercolor="#FFFFFF"> <p> $96m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Merit-eyes-1bn-embolotherapy-opportunity-with-BioSphere-buy-287573?autnID=/contentstore/clinica/codex/8bf59db6-61a2-11df-bc1e-c5d67941f290.xml">May 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> September 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Mesoblast (Australia) </p> </th> <td bordercolor="#FFFFFF"> <p> Angioblast (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Stem cell technology </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Regen-firm-Mesoblast-to-expand-beyond-ortho-with-Angioblast-buy-281654?autnID=/contentstore/clinica/codex/37451bb1-5dd4-11df-bc1e-c5d67941f290.xml">May 2010 </a> </p> </td> <td bordercolor="#FFFFFF"> <p> January 2011 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> CR Bard (US) </p> </th> <td bordercolor="#FFFFFF"> <p> SenoRx (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Peripheral vascular </p> </td> <td bordercolor="#FFFFFF"> <p> $213m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Bard-adds-breast-care-to-offerings-with-213m-SenoRx-buy-280140?autnID=/contentstore/clinica/codex/c719ffac-5c21-11df-a344-4b68910a1c57.xml">May 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> July 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Stago Group (France) </p> </th> <td bordercolor="#FFFFFF"> <p> Blood coagulation business from Trinity Biotech (Ireland) </p> </td> <td bordercolor="#FFFFFF"> <p> Haemotology </p> </td> <td bordercolor="#FFFFFF"> <p> $90m </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Trinity-shares-fall-after-coagulation-sale-to-Stago-273619?autnID=/contentstore/clinica/codex/c07c7f83-59c8-11df-a344-4b68910a1c57.xml">May 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Endo Pharmaceuticals (US) </p> </th> <td bordercolor="#FFFFFF"> <p> HealthTronics (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Urology </p> </td> <td bordercolor="#FFFFFF"> <p> $4.85 for each HealthTronics share plus debt </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Endo-set-for-medtech-market-with-HealthTronics-merger-273507?autnID=/contentstore/clinica/codex/8651ee9f-5901-11df-a344-4b68910a1c57.xml">May 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> July 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Vascular Solutions (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Smartneedle and pdAccess Doppler guided needle access business from Escalon Vascular Access (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Ultrasound </p> </td> <td bordercolor="#FFFFFF"> <p> $5.75m </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Vascular-Solutions-expands-US-ultrasound-offering-with-Escalon-buy-257817?autnID=/contentstore/clinica/codex/b8f017e8-578a-11df-a344-4b68910a1c57.xml">May 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Medtronic (US) </p> </th> <td bordercolor="#FFFFFF"> <p> ATS Medical (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Cardiovascular </p> </td> <td bordercolor="#FFFFFF"> <p> $370m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Medtronic-fleshes-out-cardiac-surgery-offerings-with-ATS-purchase-257671?autnID=/contentstore/clinica/codex/49ccc92d-539e-11df-a344-4b68910a1c57.xml">April 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> August 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> ExonHit Therapeutics (France) </p> </th> <td bordercolor="#FFFFFF"> <p> RedPath Integrated Pathology (US) </p> </td> <td bordercolor="#FFFFFF"> <p> DNA-based diagnostics </p> </td> <td bordercolor="#FFFFFF"> <p> $22.5m plus milestones </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/ExonHit-to-grow-international-Dx-business-with-RedPath-buy-256101?autnID=/contentstore/clinica/codex/9db191f5-51fd-11df-8fab-a1522d3ef0e5.xml">April 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> Terminated </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> PerkinElmer (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Signature Genomic Laboratories (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Genetic testing </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/PerkinElmer-grows-genetic-testing-capabilities-with-lab-buy-244505?autnID=/contentstore/clinica/codex/be25eccb-4889-11df-8fab-a1522d3ef0e5.xml">April 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> May 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Iridex (US) </p> </th> <td bordercolor="#FFFFFF"> <p> RetinaLabs (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Ophthalmology </p> </td> <td bordercolor="#FFFFFF"> <p> $250,000 in cash and 115,000 unregistered Iridex shares </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a href="http://www.clinica.co.uk/marketsector/other/Iridex-eyes-growth-in-newly-acquired-vitreoretinal-unit-244338?autnID=/contentstore/clinica/codex/2ef95915-462d-11df-8fab-a1522d3ef0e5.xml">April 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> CareFusion (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Medegen (Canada) </p> </td> <td bordercolor="#FFFFFF"> <p> Needleless valves </p> </td> <td bordercolor="#FFFFFF"> <p> $225m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/CareFusion-eyes-first-buy-with-225m-Medegen-acquisition-237266?autnID=/contentstore/clinica/codex/893f5ef6-4168-11df-8fab-a1522d3ef0e5.xml">April 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> May 2010 </p> </td> </tr> <tr> <td> <p> <b>Devicor Medical Products (US)</b> </p> </td> <td> <p> Breast care business of Ethicon Endo-Surgery (US) </p> </td> <td> <p> Breast Care </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Ethicon-to-shed-breast-care-business-227610?autnID=/contentstore/clinica/codex/5817c5c8-3cc9-11df-8fab-a1522d3ef0e5.xml">March 2010</a> </p> </td> <td> <p> July 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Orthopaedic Synergy (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Praxim (France) </p> </td> <td bordercolor="#FFFFFF"> <p> Orthopaedics </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Orthopaedic-Synergy-grows-with-Praxim-buy-200795?autnID=/contentstore/clinica/codex/5ece6a8d-2c3c-11df-9a1d-43f7b12171c7.xml">March 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> June 2010<i> </i> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Merck (Germany) </p> </th> <td bordercolor="#FFFFFF"> <p> Millipore (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Bioscience research </p> </td> <td bordercolor="#FFFFFF"> <p> &euro;5.3bn ($7.2bn) </p> </td> <td bordercolor="#FFFFFF"> <p> February 2010 </p> </td> <td bordercolor="#FFFFFF"> <p> July 2010 </p> </td> </tr> <tr> <td> <p> <b>Philips (the Netherlands)</b> </p> </td> <td> <p> Somnolyzer 24 x 7 automated scoring business of the Siesta Group (Austria) </p> </td> <td> <p> Sleep diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> February 2010 </p> </td> <td><p></td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Baxter International (US) </p> </th> <td bordercolor="#FFFFFF"> <p> ApaTech (UK) </p> </td> <td bordercolor="#FFFFFF"> <p> Orthopaedics </p> </td> <td bordercolor="#FFFFFF"> <p> $330m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Baxter-enters-bone-graft-market-with-ApaTech-buy-188901?autnID=/contentstore/clinica/codex/0360e66b-2544-11df-aaab-ed965f779bf8.xml">March 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> March 2010<i> </i> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Unamed privately-owned healthcare company </p> </th> <td bordercolor="#FFFFFF"> <p> SSI Surgical Services business from Teleflex (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Endoscopy </p> </td> <td bordercolor="#FFFFFF"> <p> $25m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Teleflex-to-divest-endoscopic-business-for-higher-margin-focus-188897?autnID=/contentstore/clinica/codex/1573199e-2520-11df-89ea-097de411b4b2.xml">February 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> March 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Memometal (France) </p> </th> <td bordercolor="#FFFFFF"> <p> OrthoGlide ankle implant from Advanced Bio-Surfaces (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Orthopaedics </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Memometal-purchases-OrthoGlide-ankle-tech-188649?autnID=/contentstore/clinica/codex/74b3b75b-2088-11df-9d53-495027eab048.xml">February 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> CooperSurgical (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Her Option global endometrial ablation product line from American Medical Systems (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Women's health </p> </td> <td bordercolor="#FFFFFF"> <p> $20.5m </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/AMS-divests-ablation-line-for-pelvic-health-focus-188438?autnID=/contentstore/clinica/codex/fa915667-1c7e-11df-aa51-257e2096aa2c.xml">February 2010 </a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Volcano (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Xtract thrombus aspiration catheter from Lumen Biomedical (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Coronary artery disease </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Volcano-brings-emboli-capture-technology-in-house-188156?autnID=/contentstore/clinica/codex/f5c27d30-17ce-11df-9bd3-591005c3ebcd.xml">February 2010 </a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Biocartis (Switzerland) </p> </th> <td bordercolor="#FFFFFF"> <p> DNA/RNA molecular diagnostic testing technology from Philips (the Netherlands) </p> </td> <td bordercolor="#FFFFFF"> <p> Molecular diagnostics </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Philips-sharpens-focus-on-POC-with-sale-of-molecular-diagnostics-platform-to-Biocartis-187967?autnID=/contentstore/clinica/codex/6a61bf9d-1636-11df-becf-e973a6b17cd7.xml">February 2010 </a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Allergan (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Serica Technologies (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Tissue regeneration </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/New-ortho-biomaterial-company-formed-after-Allergan-buys-Serica-187879?autnID=/contentstore/clinica/codex/48b8995f-156d-11df-97a0-4b658017be75.xml">February 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Nipro (Japan) </p> </th> <td bordercolor="#FFFFFF"> <p> Home Diagnostics (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Diabetes testing </p> </td> <td bordercolor="#FFFFFF"> <p> $215m </p> </td> <td bordercolor="#FFFFFF"> <p> February 2010 </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Home-Diagnostics-eyes-global-expansion-with-215m-Nipro-merger-187763?autnID=/contentstore/clinica/codex/296829fb-14c1-11df-8825-4143759c267b.xml">March 2010 </a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Haemonetics (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Global Med Technologies (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Blood management </p> </td> <td bordercolor="#FFFFFF"> <p> $60m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Haemonetics-to-add-Global-Med-Technologies-for-60m-187437?autnID=/contentstore/clinica/codex/c219c9fc-0fed-11df-b0f6-03cca73eb886.xml">February 2010 </a> </p> </td> <td bordercolor="#FFFFFF"> <p> March 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Thoratec (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Catheter pump technology from Getinge (Sweden) </p> </td> <td bordercolor="#FFFFFF"> <p> Circulatory support </p> </td> <td bordercolor="#FFFFFF"> <p> $8.5m </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Thoratec-to-broaden-circulatory-support-leadership-with-pump-buy-187115?autnID=/contentstore/clinica/codex/f634b456-0b37-11df-9d2c-db3d3be2dd7b.xml">January 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Cascade Technologies (Canada) </p> </th> <td bordercolor="#FFFFFF"> <p> Spectral Molecular Imaging (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Imaging </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Cascade-builds-medtech-ambitions-with-Spectral-purchase-220091?autnID=/contentstore/clinica/codex/eeb1ba49-373a-11df-ac09-b5e21662905f.xml">March 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> NeuroTherm (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Interventional spine pain management assets from Smith &amp; Nephew (UK) </p> </td> <td bordercolor="#FFFFFF"> <p> Chronic pain </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/NeuroTherm-strengthens-with-SandN-interventional-pain-buy-239437?autnID=/contentstore/clinica/codex/0d8728a8-4315-11df-8fab-a1522d3ef0e5.xml">April 2010 </a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Medtronic (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Invatec (Italy) </p> </td> <td bordercolor="#FFFFFF"> <p> Cardiovascular disease </p> </td> <td bordercolor="#FFFFFF"> <p> $500m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cardiovascular/Medtronic-eyes-European-expansion-in-500m-cardiovascular-triple-spend-187063?autnID=/contentstore/clinica/codex/f55360b4-0a69-11df-9095-c5d4846b47ba.xml">January 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> April 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Gambro (Sweden) </p> </th> <td bordercolor="#FFFFFF"> <p> CHF Solutions (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Ultrafiltration </p> </td> <td bordercolor="#FFFFFF"> <p> Undisclosed </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Gambro-adds-ultrafiltration-to-portfolio-with-CHF-buy-186925?autnID=/contentstore/clinica/codex/12fa9056-0746-11df-8a60-69091a30b1c2.xml">January 2010</a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> CryoLife (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Medafor (US) </p> </td> <td bordercolor="#FFFFFF"> <p> Haemostasis </p> </td> <td bordercolor="#FFFFFF"> <p> $2.00 per share for outright ownership </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/CryoLife-launches-hostile-takeover-bid-for-Medafor-186659?autnID=/contentstore/clinica/codex/60611333-0430-11df-af56-9be598ffc63f.xml">January 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> Terminated<i> </i> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Inverness Medical Innovations (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Standard Diagnostics (Korea) </p> </td> <td bordercolor="#FFFFFF"> <p> Disease diagnostics </p> </td> <td bordercolor="#FFFFFF"> <p> Won 40,000 ($35.67) per SD share for 76% of issued stock </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Inverness-looks-to-Korea-to-grow-POC-diagnostics-offering-186508?autnID=/contentstore/clinica/codex/0d7f1494-0114-11df-8d18-934ec0934495.xml">January 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> February 2010 </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Qiagen (The Netherlands) </p> </th> <td bordercolor="#FFFFFF"> <p> ESE (Germany) </p> </td> <td bordercolor="#FFFFFF"> <p> Optical measurement </p> </td> <td bordercolor="#FFFFFF"> <p> $19m </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Qiagen-ramps-up-molecular-Dx-offering-with-ESE-buy-186327?autnID=/contentstore/clinica/codex/882a29f8-ff73-11de-919b-5f6dbcf06b8e.xml">January 2010 </a> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Inverness Medical Innovations (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Epocal (Canada) </p> </td> <td bordercolor="#FFFFFF"> <p> POC diagnostics </p> </td> <td bordercolor="#FFFFFF"> <p> $255m </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Inverness-to-buy-Epocal-after-striking-distribution-deal-186131?autnID=/contentstore/clinica/codex/60c77fdc-fb86-11de-a7be-834da397cc1c.xml">January 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> <i>Pending </i> </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Anika Therapeutics (US) </p> </th> <td bordercolor="#FFFFFF"> <p> Fidia Advanced Biopolymers (Italy) </p> </td> <td bordercolor="#FFFFFF"> <p> Tissue regeneration </p> </td> <td bordercolor="#FFFFFF"> <p> $17.1m in cash and 1.98 million shares </p> </td> <td bordercolor="#FFFFFF"> <p> &nbsp; </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Anika-seals-FAB-deal-for-17.1m-plus-stock-185989?autnID=/contentstore/clinica/codex/fcc452b6-f9f2-11de-9819-87696bcccafb.xml">January 2010</a> </p> </td> </tr> <tr> <td> <p> <b>QuantRx Biomedical (US)</b> </p> </td> <td> <p> NuRx Pharmaceuticals (US) </p> </td> <td> <p> Point-of-care diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> January 2010 </p> </td> <td> <p> Terminated </p> </td> </tr> <tr> <th bordercolor="#FFFFFF" scope="row"> <p> Novartis (Switzerland) </p> </th> <td bordercolor="#FFFFFF"> <p> Alcon (Switzerland) </p> </td> <td bordercolor="#FFFFFF"> <p> Eye care </p> </td> <td bordercolor="#FFFFFF"> <p> $38.5bn for a 77% stake </p> </td> <td bordercolor="#FFFFFF"> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/38.5bn-Alcon-buy-puts-Novartis-in-the-lead-for-global-eye-care-185843?autnID=/contentstore/clinica/codex/8f3cb667-f93f-11de-86f8-d79ae4404f3e.xml">January 2010</a> </p> </td> <td bordercolor="#FFFFFF"> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Gamida fo</b>r<b> Life Group (the Netherlands)</b> </p> </td> <td> <p> Epoch Bioscience division of The ELITech Group's Wescor subsidiary (France) </p> </td> <td> <p> Microarray </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> January 2010 </p> </td> <td> <p> January 2010 </p> </td> </tr> <tr> <td> <p> <b>Predictive Biosciences (US)</b> </p> </td> <td> <p> OncoDiagnostic Laboratory (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> January 2010 </p> </td> <td> <p> January 2010 </p> </td> </tr> <tr> <td> <p> <b>Christie Digital Systems (US) </b> </p> </td> <td> <p> Luminetx (US) </p> </td> <td> <p> Vascular imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/Luminetx-to-sell-assets-to-Christie-Digital-Systems-182025?autnID=/contentstore/clinica/codex/0190f0b1-e348-11de-bc8c-f1448de876e6.xml">December 2009</a> </p> </td> <td> <p> January 2010 </p> </td> </tr> <tr> <td> <p> <b>Private equity consortium</b> </p> </td> <td> <p> deCODE genetics (Iceland) </p> </td> <td> <p> Human genetics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> January 2010 </p> </td> <td> <p> January 2010 </p> </td> </tr> </table> <p> <a class="optionsLink" href="http://www.clinica.co.uk/MnA#top">Back to the top</a><br> <br> <a name="latest" id="latest"> </a> </p> 
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 29

Mergers amp Acquisitions 2010
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20160622T185746
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT057953
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 31

Mergers &amp; Acquisitions 2010
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

311178
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T190239Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

bfc87017-bec2-42a8-82d3-fbbcbfaefb52
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T225746Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 14

sitecore\admin
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
